Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report

Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report

  • Products Id :- 76F176AF-EC8B-4468-BC95-51DE4F9A6DDD
  • |
  • Pages: 43
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Sanofi Genzyme-Strategy, SWOT and Corporate Finance Report


Sanofi Genzyme-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Sanofi Genzyme (Genzyme), a specialty care global business unit of Sanofi provides treatments with a focus on rare diseases, multiple sclerosis, immunology, and oncology. The major products of the company include Aldurazyme, Aubagio, Caprelsa tablets, Cerdelga capsules, Cerezyme, Clolar, Dupixent injection, Elitek, Eloxatin, Fabrazyme, Jevtana, Kevzara injection, Lemtrada, Lumizyme, Mozobil injection, Taxotere injection concentrate, Thymoglobulin, Thyrogen and ZALTRAP injection for intravenous infusion. The company also addresses the unmet needs in immune diseases including atopic dermatitis, rheumatoid arthritis, asthma, nasal polyposis, and eosinophilic esophagitis. The company primarily operates in the Americas and Europe. Genzyme is headquartered in Cambridge, Massachusetts, the US.


- Detailed information on Sanofi Genzyme required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Sanofi Genzyme in the form of a SWOT analysis

- An in-depth view of the business model of Sanofi Genzyme including a breakdown and examination of key business segments

- Intelligence on Sanofi Genzyme's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Sanofi Genzyme, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sanofi Genzyme and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Sanofi Genzyme as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Sanofi Genzyme's business structure, strategy and prospects.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Company Snapshot 2

Table of Contents 5

Sanofi Genzyme: Company Overview 9

Sanofi Genzyme: Overview and Key Facts 9

Sanofi Genzyme: Overview 9

Sanofi Genzyme: Key Facts 9

Sanofi Genzyme: Key Employees 10

Sanofi Genzyme: Key Employee Biographies 12

Sanofi Genzyme: Major Products and Services 14

Sanofi Genzyme: Company History 15

Sanofi Genzyme: Locations and Subsidiaries 21

Sanofi Genzyme: Key Competitors 22

Sanofi Genzyme: Company Analysis 23

Sanofi Genzyme: Business Description 23

Sanofi Genzyme: SWOT Analysis 25

Sanofi Genzyme: SWOT Overview 25

Sanofi Genzyme: Strengths 25

Sanofi Genzyme: Weaknesses 26

Sanofi Genzyme: Opportunities 26

Sanofi Genzyme: Threats 27

Sanofi Genzyme: Corporate Financial Deals Activity 28

Sanofi Genzyme: Financial Deals Overview 28

Sanofi Genzyme: Targets and Partners 29

Sanofi Genzyme: Top Deals 2014-2018YTD 30

Sanofi Genzyme: Mergers and Acquisitions 31

Sanofi Genzyme: Partnership 32

Sanofi Genzyme: Recent Developments 33

Sanofi Genzyme: News and Events Summary 33

Sanofi Genzyme: Contracts 36

Sanofi Genzyme: Market Developments 36

Sanofi Genzyme: Regulatory and Legal Events 38

Sanofi Genzyme: Research & Development 39

Sanofi Genzyme: Strategy and Operations 40

Appendix 41

Contact Us 41

Methodology 41

About MarketLine 42

List of Figures

Figure 1: Sanofi Genzyme: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 2: Sanofi Genzyme: M&A Average Deal Size-Value (USD m)

Figure 3: Sanofi Genzyme: M&A Volume and Value Trend (2014-YTD 2018)

Figure 4: Sanofi Genzyme: Partnership Volume and Value Trend (2014-YTD 2018)

Figure 5: San

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

select a license
Single User License
USD 175 INR 12758
Site License
USD 350 INR 25515
Corporate User License
USD 525 INR 38273



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]